The idea that mutations in BMPR2 confer a phenotype of mal-adaption to injury is supported by studies in human patients, which demonstrate a more severe clinical phenotype of PAH in carriers of a mutated BMPR2 allele [40]–[44]. The gene discussed is BMPR2; the disease is pulmonary arterial hypertension.